Use this dropdown to select your preferred language.
Budweiser Brewing Company APAC Limited (“Bud APAC”) is the largest beer company in Asia Pacific, with leadership positions in Premium and Super Premium beer segments. Through its local subsidiaries, Bud APAC operates in its principal markets, including China, South Korea, India and Vietnam. Headquartered in Hong Kong SAR, China, Bud APAC operates 47 breweries and employs more than 24,000 colleagues across APAC.
SABIC is a global leader in diversified chemicals headquartered in Riyadh, Saudi Arabia. We manufacture on a global scale, making distinctly different kinds of products:chemicals, commodity and high performance plastics, agri-nutrients and metals. SABIC operates in more than 50 countries with around 40,000 employees globally.
Established in Republic of Korea in 1987, SABIC has 3 sites and 1 JV Site(SABIC SK Nexlene Company) in the country.
CHEP manages the world’s largest pool of reusable pallets and containers.
We promote the shared use of our platforms among supply chain participants under a circular ‘share and reuse’ model known as pooling.
Through our inherently sustainable operating model, superior network advantage and industry expertise, we lead the market in more efficient and sustainable supply chains.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. In Pakistan, GSK provides trusted quality medicines and vaccines to more than 200 million patients for over seven decades. We aspire to capitalize on our leadership position by growing our general medicines portfolio, introducing innovative therapies, and using digital solutions.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.